Hepatic veno-occlusive disease | |
---|---|
Other names | Veno-occlusive disease with immunodeficiency Sinusoidal obstruction syndrome |
Specialty | Gastroenterology |
Symptoms | Weight gain, tender enlargement of the liver, ascites, jaundice |
Diagnostic method | Liver biopsy |
Differential diagnosis | Budd–Chiari syndrome |
Prevention | Ursodeoxycholic acid |
Treatment | Defibrotide |
Deaths | 10-20% |
Hepatic veno-occlusive disease (VOD) or veno-occlusive disease with immunodeficiency is a potentially life-threatening condition in which some of the small veins in the liver are obstructed. It is a complication of high-dose chemotherapy given before a bone marrow transplant and/or excessive exposure to hepatotoxic pyrrolizidine alkaloids. It is classically marked by weight gain due to fluid retention, increased liver size, and raised levels of bilirubin in the blood.[1] The name sinusoidal obstruction syndrome (SOS) is preferred if hepatic veno-occlusive disease happens as a result of chemotherapy or bone marrow transplantation.[1][2]
Apart from chemotherapy, hepatic veno-occlusive disease may also occur after ingestion of certain plant alkaloids such as pyrrolizidine alkaloids (in some herbal teas),[1] and has been described as part of a rare hereditary disease called hepatic venoocclusive disease with immunodeficiency (which results from mutations in the gene coding for a protein called SP110).[3]